C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2011
11/29/2011	US8067533 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/29/2011	US8067247 Use of anti-CD100 antibodies for the treatment of inflammatory disorders affecting the central or peripheral nervous system
11/29/2011	US8067232 Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase
11/29/2011	US8067229 Ucp4
11/29/2011	US8067221 Von Willebrand factor (vWF)-cleaving protease
11/29/2011	US8067199 Anti-IL13 antibodies and uses thereof
11/29/2011	US8067186 Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
11/29/2011	US8067167 Hybrid antibodies
11/29/2011	US8067015 Delivery device for topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration coated with a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance
11/29/2011	US8067008 Peptide inhibitors for mediating stress responses
11/29/2011	US8067006 Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
11/29/2011	US8067005 Divalent antibody fragments
11/29/2011	US8067004 Surface antigen
11/29/2011	US8067002 Humanized anti-factor D antibodies
11/29/2011	US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/29/2011	US8066999 PEGylated Aβ fab
11/29/2011	US8066994 Proteins comprising an IgG2 domain
11/29/2011	US8066993 Use of ventricular enlargement rate in intravenous immunoglobulin treatment of Alzheimer's disease
11/29/2011	US8066992 Medicament and a method of treating a pathological syndrome
11/29/2011	US8066991 Enzyme inhibitors of PAI-1
11/29/2011	CA2624935C Anti-myostatin antibodies
11/29/2011	CA2525657C Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats o6 of pseudomonas aeruginosa
11/29/2011	CA2442909C Multimerization of hiv-1 vif protein as a therapeutic target
11/29/2011	CA2440461C Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
11/29/2011	CA2401438C Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
11/29/2011	CA2342199C Monoclonal antibodies against s100
11/29/2011	CA2293632C Artificial antibody polypeptides
11/29/2011	CA2235224C Diagnostics and treatments of periodontal disease
11/29/2011	CA2233447C Mimicking peptides in cancer therapy
11/29/2011	CA2232626C Novel affinity ligands and their use
11/24/2011	WO2011146891A2 High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins
11/24/2011	WO2011146862A1 Methods for inducing selective apoptosis
11/24/2011	WO2011146727A1 Methods of treating interstitial cystitis
11/24/2011	WO2011146568A1 Predicting response to a her inhibitor
11/24/2011	WO2011146479A1 Method and composition for the diagnosis and monitoring of inflammatory diseases
11/24/2011	WO2011145744A1 Anti-human trop-2 antibody having antitumor activity in vivo
11/24/2011	WO2011145725A1 Method and kit for diagnosing aim-related illness
11/24/2011	WO2011145664A1 Sulfur-containing amino acid derivative
11/24/2011	WO2011145629A2 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION
11/24/2011	WO2011145085A2 Novel antibodies and methods of use for the treatment and diagnosis of cancer
11/24/2011	WO2011144751A1 Improved anti-serum albumin binding variants
11/24/2011	WO2011144749A1 Biological materials related to her3
11/24/2011	WO2011144640A1 Novel c3c epitope, antibodies binding thereto, and use thereof
11/24/2011	WO2011143716A1 Gene constructs comprising nucleic acids that modulate chlorophyll biosynthesis and uses thereof
11/24/2011	WO2011120135A8 Antibodies with enhanced or suppressed effector function
11/24/2011	WO2011120134A8 Antibodies with enhanced or suppressed effector function
11/24/2011	WO2011109400A3 Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
11/24/2011	WO2011109298A3 Therapeutic dll4 binding proteins
11/24/2011	WO2011101634A3 Methods of prevention or treatment of triggered inflammatory reactions using tumor necrosis factor alpha antagonist
11/24/2011	WO2011092715A3 Method for in-vivo binding of chromatin fragments
11/24/2011	WO2011090719A3 Protein purification by ion exchange
11/24/2011	WO2011088385A3 Compositions and methods for detecting cancer
11/24/2011	WO2011085165A3 Ca-125 immune complexes as biomarkers of ovarian cancer
11/24/2011	WO2011063198A3 Methods and compositions for modulating the activity of the interleukin-35 receptor complex
11/24/2011	WO2011056056A3 Anti-cytokine vhnar domains
11/24/2011	WO2010131114A3 Carbohydrate binding module and use thereof
11/24/2011	US20110289622 Expression cassettes for transgenic expression of nucleic acids
11/24/2011	US20110289604 Methods for Identifying Modulating Compounds of Lymphangiogenesis, Means Therefore, Compounds and Uses Thereof
11/24/2011	US20110288279 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
11/24/2011	US20110288278 Diagnostic agent and therapeutic agent for pancreatic cancer
11/24/2011	US20110288276 CRYSTALS AND STRUCTURE OF A HUMAN IgG Fc VARIANT WITH ENHANCED FcRn BINDING
11/24/2011	US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011	US20110288269 Design of Spacers To Increase The Expression of Recombinant Fusion Proteins
11/24/2011	US20110288151 Methods of characterizing breast cancer and identifying treatments for same
11/24/2011	US20110288034 Methods of identifying adipocyte specific genes, the genes identified, and their uses
11/24/2011	US20110288024 Compositions and Methods for Treating Arthritis and/or Diseases Involving Cartilage Degeneration
11/24/2011	US20110287979 Methods for Identifying and Isolating Cells Expressing a Polypeptide
11/24/2011	US20110287969 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
11/24/2011	US20110287960 Method For Producing Monoclonal Antibodies
11/24/2011	US20110287955 Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis
11/24/2011	US20110287533 Novel lowered affinity antibodies and uses therefor
11/24/2011	US20110287486 Method for In Vitro Molecular Evolution of Protein Function
11/24/2011	US20110287480 Neurogenin
11/24/2011	US20110287458 Method and composition for the diagnosis and monitoring of inflammatory diseases
11/24/2011	US20110287453 Antibody binding specifically to tdp-43 aggregate
11/24/2011	US20110287451 Novel anti cxcr4 antibodies and their use for the treatment of cancer
11/24/2011	US20110287448 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
11/24/2011	US20110287445 Mutant ROS Expression In Human Cancer
11/24/2011	US20110287444 Immunoassay method for human cxcl1 protein
11/24/2011	US20110287441 Methods and materials for assessing enzyme-nucleic acid complexes
11/24/2011	US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT
11/24/2011	US20110287410 Hepatitis-c virus testing
11/24/2011	US20110287406 Novel HCV core+1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents
11/24/2011	US20110287088 Modulation of olfml-3 mediated angiogenesis
11/24/2011	US20110287084 Method for reducing body fat and increasing lean body mass by reducing stearoyl-coa desaturase 1 activity
11/24/2011	US20110287063 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/24/2011	US20110287049 Prevention and treatment of amyloidogenic diseases
11/24/2011	US20110287046 Modified streptococcus pneumonia pneumolysin (ply) polypeptides
11/24/2011	US20110287044 Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv
11/24/2011	US20110287043 Melanoma antigens and their use in diagnostic and therapeutic methods
11/24/2011	US20110287036 Novel cancer targeting therapy using complex of subtance capable of binding specifically to constituent factor of cancer stroma and anti-tumor compound
11/24/2011	US20110287032 Novel ctla4-ig immunoadhesins
11/24/2011	US20110287025 Combination therapy and method for assessing resistance to treatment
11/24/2011	US20110287024 Vascular endothelial cell growth factor antagonists
11/24/2011	US20110287021 Neoplasm specific antibodies and uses thereof
11/24/2011	US20110287019 Therapeutic targeting of escort proteins
11/24/2011	US20110287016 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
11/24/2011	US20110287015 Mg53 compositions and methods of use
11/24/2011	US20110287014 Antibodies directed against calcium channel subunit alpha2/delta and methods using same
11/24/2011	US20110287013 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof

1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 1494